Delcath Systems, Inc.

DCTH ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $2.7M $-26.4M $-47.7M $-36.5M $-25.6M $-24.2M $-8.9M $-19.2M
Depreciation & Amortization — — — — — — — —
Depreciation $238.0K $134.0K $128.0K $132.0K $146.0K $167.0K $212.0K $444.0K
Amortization — — — — — — — —
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $22.5M $-18.7M $-31.3M $-25.0M $-22.6M $-22.9M $-23.7M $-14.7M
Investing Activities
Capital Expenditures $1.5M $559.0K $58.0K $209.0K $143.0K $782.0K $24.0K $76.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-26.6M $-981.0K $-19.7M $-209.0K $-143.0K $-782.0K $-24.0K $-76.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $6.0M $0 — — — — — —
Net Cash from Financing Activities $15.0M $39.4M $51.8M $10.1M $20.8M $42.4M $30.3M $13.2M
Net Change in Cash $11.0M $19.7M $874.0K $-15.1M $-1.8M $18.6M $6.6M $-1.7M
Free Cash Flow $21.0M $-19.2M $-31.3M $-25.2M $-22.7M $-23.7M $-23.7M $-14.8M
← Newer Page 1 of 3 Older →